Autres langues Sana Biotechnology, Inc.

Actions

SANA

US7995661045

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 13/05/2024			Varia. 5j.	Varia. 1 janv.
7,91 ^USD	+4,63 %		-20,90 %	+93,87 %

08/05	Sana Biotechnology, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
18/04	Sana Biotechnology, Inc. annonce la démission de Douglas Williams de son poste de vice-président exécutif et de président de la recherche et du développement	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sana: Q1 Earnings Snapshot	08/05
Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates	08/05
Sana Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Sana Biotechnology to Present at May and June 2024 Investor Conferences	06/05
Sana Biotechnology, Inc. Announces Resignation of Douglas Williams as Executive Vice President and President, Research and Development	18/04
Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences	09/04
Certain Restricted Stock Units of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 9-APR-2024.	09/04
Certain Stock Options of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 9-APR-2024.	09/04
Certain Common Stock of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 9-APR-2024.	09/04
Sana Biotechnology Shares Rise as Q4 Non-GAAP Net Loss Narrows	01/03
Sector Update: Health Care Stocks Edge Higher Premarket Friday	01/03
Sana Biotechnology Q4 Non-GAAP Net Loss Narrows; Cash, Cash Equivalents Decline	29/02
Sana: Q4 Earnings Snapshot	29/02
Sana Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Sana Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates	29/02
Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference	28/02
Viridian Therapeutics Names Jennifer Tousignant as Chief Legal Officer	16/02
Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP	13/02
Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP	13/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Sana Biotechnology, Inc.

Actions

SANA

US7995661045

Autres langues

Filtres